semaglutide bpc 157 b6 Can You Take BPC-157 with GLP-1 Medications (Semaglutide)? Semaglutide/BPC – 157

CagriSema produced unprecedented mean weight loss of 20.4% at 68 weeks on an intent-to-treat basis, significantly exceeding semaglutide alone (14.9%), cagrilintide alone (11.5%), and placebo (3.0%)

The published research base, predominantly preclinical with growing clinical extension, identifies several mechanisms of action

Hsieh et al., 2017) (see The Effect on Other Tissues Healing as Support )

"Health Canada won't approve it as a drug, but it slips through as a compounded natural health product, where the federal safety check basically doesn't happen." Health Canada considers NHP compounding within a practitioner-patient relationship distinct from manufacturing and not subject to the same regulatory oversight

The combination isn't FDA-approved and is only available through research studies with strict eligibility criteria

At the time, the FDAs panel of pharmacy advisors voted overwhelmingly that the peptides did not meet the criteria for substances that can be safely compounded